Your privacy choices

Essential storage keeps the site working. With your permission, we also measure visits and interactions on public research pages using first-party analytics. Optional third-party analytics and advertising trackers are currently disabled.

Read our privacy policy
Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

STERIS plc

STENYSE
Wall Street Score · overall investment47/100
$208.54USD$-0.80 (-0.38%)
Company website www.steris.com
Headquarters5960 Heisley Road, Mentor, OH, 44060, US
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Specialties
Price updated todayFinancials updated Oct 1, 2026
Price Chart$-18.29 (-8.06%)
2026-09-042026-09-092026-09-112026-09-152026-09-172026-09-212026-09-232026-09-252026-09-292026-10-02$204.00$210.00$216.00$222.00$228.00

Company & revenue

About STERIS plc

Who they are

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions.

Detailed revenue, brand and relationship research has not yet been completed for STE.

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

47

Weak

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

82

Strong

Financial Strength

82

Business Quality / Moat

94

Management

99

Growth Quality

34

Risk / Durability

86

Great Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

49

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

57/100

Building Historical Record

Model Score 57/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

WSS currently sees meaningful weaknesses in the company-strength profile.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently moderate.

What we like
  • •Balance-sheet / debt profile scores strongly
  • •Recent buyback activity is present
What to watch
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak
  • •Asset quality is a weaker factor

Company-specific research

Questions worth answering for STE

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can STE maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is STE's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •Is STE's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • •What future growth or profitability would be needed to justify STE's current valuation?
Business analysis: 40 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

47

0–100 · Weak

Opportunity Score

49

0–100 · Weak

Market Cap

$20.32B

P/E Ratio

25.5

EPS

$8.20

52-Week High

$269.44

52-Week Low

$195.14

Beta

0.91

Intrinsic Value

$223.50

Analyst Target

$270.00

Shares Outstanding

98.7M

Total Revenue

$6.04B

Total Debt

$2.04B

Dividend Yield

1.19%

View dividend history

Liquidation Value / Share

$73.16

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
34/ 100
+1 pts / 5d

Weakening momentum

5D -0.2% · 20D -8.1% · RSI 37 · Price vs 20D avg -1.2%
Volatility
8/ 100
-1 pts / 5d

Low movement

20D realized vol 16.6% · 60D 24.3% · Acceleration 0.68x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for STE

Detected from reported data — verify before acting.

Dividend history reported

The provider reports a dividend yield. Confirm the latest declaration before treating it as a current payment.

Historical repurchase activity

Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on STE.

What the Bulls Say

  • +Product opportunity: STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contra.
  • +Positive free cash flow may provide capacity to invest in growth.

What the Bears Say

No strong bearish data point is currently available.

Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak47/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Weak

47

Tap for breakdown →

Elite

92

Debt Cost2.9%
Debt Reduction YoY5.2%
Debt / Equity0.29x

Tap for breakdown →

Poor

20

Revenue YoY1.7%
Revenue CAGR7.5%
Net Margin13.3%

Tap for breakdown →

Poor

33

Asset Growth YoY5.8%
Liquidation/Share$73.16
Net Assets/MCap0.43x

Tap for breakdown →

Poor

27

Earnings Yield4.0%
Buyback Yield0.9%
Debt Cost2.9%

Tap for breakdown →

Elite

99

ROIC9.4%
ROE11.2%
ROA7.5%

Tap for breakdown →

Elite

94

EPS Growth32.6%
FCF/Share Growth21.3%
Rev/Share Growth9.1%

Tap for breakdown →

Poor

28

Intrinsic Value$223.50
Value Reference$134.10
MOS0.1%

Tap for breakdown →

Fair

64

Revenue20
Moat94
Valuation28

Tap for breakdown →

Poor

16

MOS %0.1%
Value Reference$134.10
Deep Discount Reference$89.40

Tap for breakdown →

Poor

34

Interest Coverage18.2x
ROIC9.4%
FCF Yield4.8%

Tap for breakdown →

Poor

37

Financial34
Valuation28
Debt92

Tap for breakdown →

Strong

71

Survival Years0.6 yrs
Current Ratio2.09x
FCF Margin0.2%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

2 historical score records available

Previous Score

45

Jul 24, 2026

Change

+2.1

points

Current Score

47

Oct 1, 2026

Category Changes

Revenue+1.9
Debt0
Assets+0.2
Capital+1.0
Management+0.1
Moat+0.1
Valuation+10.1
Buffett+1.4

STE increased 2.1 points because Valuation improved by 10.1 points.

Positive Contributors

  • + Valuation improved by 10.1 points

Projected Score

Projected Score

50

Projected Change

+2.6%

Preliminary comparable-period financial changes suggest improvement of approximately 2.6 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Near Fair Value

Current Price

$208.54

Intrinsic Value

$223.50

Difference

−$14.96

-6.7% vs IV

Margin of Safety

6.7%

UndervaluedFair ValueOvervalued
Value Reference: $134.10
Deep Discount Reference: $89.40

Related Companies

Medical - Specialties

BWAY

BrainsWay Ltd.

54Fair
$12.50View

SI

Shoulder Innovations, Inc.

38Poor
$19.01View

ALC

Alcon Inc.

35Poor
$63.76View

DRIO

DarioHealth Corp.

34Poor
$6.46View

ITOC

iTonic Holdings Ltd.

33Poor
$0.25View

WOK

WORK Medical Technology Group Ltd. Class A

29Poor
$1.71View

News

Defense World4d ago

Rep. Kevin Hern Unloads Shares of Honeywell International Inc. (NASDAQ:HON)

Defense World4d ago

Crane (NYSE:CR) Stock Sold Off by Rep. Kevin Hern

Defense World4d ago

Colgate-Palmolive (NYSE:CL) Stock Sale Revealed by Rep. Kevin Hern

Defense World4d ago

Walmart (NASDAQ:WMT) Shares Unloaded by Rep. Kevin Hern

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksBest healthcare stocksHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial